Free Newsletter
Genetic tinkering creates obesity-resistant mice
A research team developed a group of transgenic mice that were unable to release a subset of GABA neurotransmitters, creating a breed of rodents that was resistant to obesity. The scientific team says the mice ate the same amount as a control group, but that they were engineered to burn energy at a much faster pace. The genetic tinkering also made the mice more resistant to the hormone ghrelin, which creates a feeling of hunger.
The researchers also helped explain the role of pro-opiomelanocortin (POMC) neurons that receive the GABA signal.
"The function of AgRP neurons is probably to reserve the energy for maintaining life," said lead study author Qingchun Tong. "So if the animal doesn't have enough food, the animal should have some strategy to preserve energy, and this group of neurons, by releasing GABA, restrains energy expenditure to maintain enough energy to survive under the conditions in which food is not readily available."
- see this report for more
Related Articles:
Obesity drugs pose weighty problems for researchers
LRPR1: A new target for obesity, diabetes
Common virus is a culprit in obesity
Molecular research points to new obesity therapy
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: